Best Choline Supplement for Fatty Liver

The best choline supplement for fatty liver is a question many people ask as interest in nutritional approaches to liver health grows. Choline is an essential nutrient that plays a direct role in transporting fat out of the liver, and deficiency is linked to the accumulation of fat in liver cells, a hallmark of metabolic dysfunction-associated steatotic liver disease (MASLD). This article explains how choline works, what the evidence says about supplementation, which forms are available in the UK, how much to take, and what safety considerations to keep in mind before starting.

What is choline and why does it matter for a fatty liver?

Choline is essential for producing phosphatidylcholine, which enables the liver to export fat via VLDL particles; insufficient choline impairs this mechanism, causing triglycerides to accumulate in liver cells and contributing to fatty liver disease.

Choline is an essential nutrient that plays a central role in fat metabolism within the liver, and inadequate levels are directly linked to the accumulation of fat in liver cells. Although the body can synthesise small amounts of choline, the majority must come from dietary sources such as eggs, liver, fish and certain legumes. Choline is classified as an essential nutrient by the European Food Safety Authority (EFSA), which has published Dietary Reference Values for choline, reflecting the fact that most people cannot produce enough endogenously to meet their needs.

Within the liver, choline is required to produce phosphatidylcholine, a phospholipid that forms the structural backbone of very-low-density lipoprotein (VLDL) particles. These particles are responsible for transporting fat out of the liver and into the bloodstream. When choline is insufficient, this export mechanism is impaired, and triglycerides accumulate within hepatocytes, a process that can contribute to or worsen non-alcoholic fatty liver disease (NAFLD). This condition is now increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), following a multi-society international consensus published in 2023 and endorsed by the European Association for the Study of the Liver (EASL).^[6][7]

Choline also supports mitochondrial function and helps regulate gene expression involved in lipid metabolism. Controlled dietary depletion studies, including work by the Zeisel research group, have demonstrated that a choline-deficient diet can induce measurable liver fat accumulation in healthy volunteers within weeks. Observational studies have found that populations with lower dietary choline intake tend to have higher rates of liver steatosis. These findings underline why choline is considered particularly relevant in the context of fatty liver disease, even though it is not yet a standard therapeutic target in UK clinical guidelines.

Does taking a choline supplement actually help fatty liver disease?

Evidence is promising but not conclusive; no UK guideline recommends choline supplements for fatty liver, and NICE NG49 prioritises lifestyle modification, weight loss and risk stratification over supplementation.

The evidence that choline supplementation meaningfully reduces liver fat in people with established fatty liver disease is promising but not yet conclusive. No UK clinical guideline currently recommends choline supplements as a treatment for NAFLD or MASLD. In particular, NICE guideline NG49 (Non-alcoholic fatty liver disease: assessment and management) does not include choline supplementation among its recommendations, and NHS patient-facing information on fatty liver disease similarly does not endorse it.^[2][3] Most of the supporting data comes from observational studies, animal models and small human trials rather than large, well-powered randomised controlled trials, so the clinical evidence base remains limited.

Several studies have shown that correcting choline deficiency in individuals with low dietary intake can reduce markers of liver injury, including alanine aminotransferase (ALT) levels, and may modestly reduce hepatic steatosis on imaging, though these findings come from preliminary research rather than definitive trials. A 2012 observational study published in the American Journal of Clinical Nutrition (Fischer et al., Am J Clin Nutr 2010; and related work by Guerrerio et al., Am J Clin Nutr 2012) found an association between higher dietary choline intake and lower rates of liver fibrosis in women; however, as an observational finding, this reflects association rather than causation and may be subject to confounding. It is also important to distinguish between correcting a deficiency and supplementing beyond normal requirements, as the latter has not been shown to produce additional benefit in people who are already choline-replete.

For people considering supplementation, it is advisable to discuss this with a GP or registered dietitian before starting, particularly if liver disease has already been diagnosed. NICE NG49 emphasises lifestyle modification, including weight loss and dietary improvement, as the primary intervention for NAFLD/MASLD. The guideline also recommends initial risk stratification using the FIB-4 score to assess the likelihood of advanced fibrosis, with consideration of the Enhanced Liver Fibrosis (ELF) test and referral to hepatology where indicated. Supplementation alone is unlikely to be sufficient without addressing underlying contributing factors such as obesity, insulin resistance, alcohol intake and overall diet quality.

Which form of choline supplement is most effective?

Phosphatidylcholine is most directly involved in hepatic fat export, but robust comparative trials are lacking; choline bitartrate is the most widely available and affordable UK option for correcting dietary insufficiency.

Choline supplements are available in several forms. Phosphatidylcholine is the form most directly involved in hepatic fat export, as it is the specific molecule incorporated into VLDL particles, and some preliminary clinical studies have examined oral phosphatidylcholine preparations and reported reductions in liver enzyme levels and steatosis. However, robust comparative trials between choline forms for liver-specific outcomes are lacking, and any suggestion that phosphatidylcholine or CDP-choline (citicoline) is definitively superior to simpler forms such as choline bitartrate or choline chloride for liver health should be regarded as biologically plausible rather than established by high-quality evidence. It should also be noted that intravenous phosphatidylcholine preparations used in some research settings are not UK food supplements and are not available outside clinical or research contexts.

Choline bitartrate is the most widely available and affordable form in the UK supplement market. It is readily absorbed and raises plasma choline levels effectively, making it a reasonable option for correcting dietary insufficiency. However, a proportion of orally ingested choline, regardless of form, is converted by gut bacteria into trimethylamine (TMA), which is then oxidised in the liver to trimethylamine N-oxide (TMAO). Some studies and meta-analyses have associated higher circulating TMAO levels with an increased risk of cardiovascular events, though the causal relationship remains debated and the clinical significance of TMAO arising specifically from supplement use is not yet established.^[10][11]

Alpha-GPC (alpha-glycerylphosphorylcholine) is another form with good bioavailability, though it is more commonly studied in the context of cognitive function than liver health. When choosing a supplement, it is worth looking for products manufactured to Good Manufacturing Practice (GMP) standards and, where possible, carrying third-party quality certification. In the UK, food supplements are regulated under the Food Supplements (England) Regulations 2003, with equivalent regulations applying in Scotland, Wales and Northern Ireland.^[12] The UK Food Standards Agency (FSA) provides guidance on food supplement safety and labelling. Supplements are not subject to the same pre-market approval process as licensed medicines, though they must comply with general food law and post-market safety requirements, so quality can vary between manufacturers.

How much choline should you take if you have a fatty liver?

EFSA recommends an Adequate Intake of 400 mg per day for adults, with no NICE-endorsed therapeutic dose for fatty liver; research studies have used 500 to 2,000 mg daily, but a GP or dietitian should be consulted before supplementing.

EFSA has established an Adequate Intake (AI) for choline of 400 mg per day for adult women and 400 mg per day for adult men, rising to 480 mg per day during pregnancy and 520 mg per day during breastfeeding, as set out in its Scientific Opinion on Dietary Reference Values for choline. These figures represent population-level estimates of sufficiency rather than therapeutic doses for liver disease, and there is currently no NICE-endorsed therapeutic dosing recommendation for choline supplementation in the context of NAFLD or MASLD.

In clinical research studies examining liver outcomes, doses have typically ranged from 500 mg to 2,000 mg per day of various choline forms, though these studies are not of sufficient size or quality to translate directly into a standard clinical recommendation. Most UK supplement products provide between 250 mg and 600 mg of choline per serving, though this varies between manufacturers. For individuals whose dietary intake is already adequate, supplementing at the lower end of this range is unlikely to cause harm at doses well below the EFSA Tolerable Upper Intake Level of 3,500 mg per day (see the safety section below), but may also offer limited additional benefit.^[1]

Before starting any supplementation regimen, particularly at higher doses, it is important to speak with a GP or registered dietitian. This is especially relevant for people with existing liver conditions, those taking medications that affect liver metabolism, or those with cardiovascular risk factors given the TMAO considerations discussed above. Dietary sources of choline, including eggs, chicken, fish and cruciferous vegetables, should be considered alongside any supplementation, as whole-food sources provide additional nutritional benefits that isolated supplements cannot replicate. A healthcare professional can help assess whether dietary intake is genuinely insufficient before recommending supplementation.

Are there any side effects or safety concerns to be aware of?

High doses above 3,500 mg per day can cause nausea, fishy body odour and low blood pressure; choline also converts partly to TMAO, which some studies link to cardiovascular risk, so those with heart disease should seek GP advice first.

Choline supplements are generally well tolerated at doses close to the Adequate Intake, but higher doses can cause side effects including a fishy body odour, nausea, vomiting, excessive sweating, low blood pressure and diarrhoea.^[1] EFSA has set a Tolerable Upper Intake Level (UL) for choline of 3,500 mg per day for adults, based on its Scientific Opinion on Dietary Reference Values for choline, above which adverse effects become more likely.^[1] Most commercially available supplements fall well below this threshold when used as directed.

The conversion of choline to TMAO via gut bacteria is a safety consideration that has attracted increasing research attention. Some studies have associated higher circulating TMAO levels with an increased risk of cardiovascular events, though the causal relationship remains debated and the clinical significance of TMAO from supplement use specifically is not yet established.^[10][11] People with pre-existing cardiovascular disease or significant cardiovascular risk factors may wish to discuss this with their GP before starting choline supplementation.

As with all food supplements sold in the UK, choline products must comply with general food law and post-market safety requirements, but they are not required to undergo pre-market authorisation in the same way as licensed medicines. The UK Food Standards Agency provides guidance on these requirements. If you experience an unexpected or concerning reaction to a supplement, you can report it to the MHRA via the Yellow Card scheme at yellowcard.^[13][14]mhra.gov.uk. If you develop symptoms such as persistent nausea, jaundice, significant abdominal pain or unexplained fatigue while taking any supplement, contact your GP promptly. For severe or sudden symptoms, call 999 or go to your nearest accident and emergency department. Anyone with a confirmed diagnosis of fatty liver disease should ensure their condition is being monitored by a healthcare professional, as supplementation is not a substitute for medical management.

Frequently Asked Questions